Gemcitabine plus concurrent irreversible electroporation vs gemcitabine alone for locally advanced pancreatic cancer

Figure 1 A 56-year-old woman who underwent gemcitabine plus concurrent for pancreatic head cancer. A: Enhanced computed tomography image showing a pancreatic head tumor measuring 3.9 cm × 4.8 cm; B: Irreversible electroporation ablation was performed; C: The tumor has shrunk to 3.5 cm × 2.1 cm 6 mo post-irreversible electroporation.